Popular search terms:
Search Results
126 results found-
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
CSL Behring Australia's Product Information (PI), Consumer Medicine Information (CMI), Safety Data Sheets and New Zealand Data Sheet
https://www.cslbehring.com.au/products/products-list -
The potency of C1 esterase inhibitor is expressed in International Units (IU), which are related to the current WHO Standard for C1 esterase inhibitor products.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/berinert-sc-2000-and-3000-au-pi-v400.pdf -
Privigen NZ DS 21.00 Page 3 of 19 NEW ZEALAND DATA SHEET In patients at risk for acute renal failure or thromboembolic adverse reactions, IVIg products should be administered at the minimum rate of infusion and dose practicable.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/privigen-nz-ds-2100.pdf -
Social Media Community Guidelines for CSL Behring Corporate Channels
https://www.cslbehring.com.au/social-guidelines -
Taking other About blood products Tell your doctor if you are on medicines a controlled sodium diet.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/berinert-sc-2000-and-3000-au-cmi-v400.pdf -
The CSL (Australia) Graduate Program is a two-year program focused on providing you with career opportunities within our CSL Behring and Seqirus global businesses.
https://www.cslbehring.com.au/careers/graduate-program/graduate-streams